Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

20,449 total articles

Opus Genetics to Present OPGx-BEST1 Cohort 1 Clinical Data in Investor Webcast and at Upcoming Leading Ophthalmology Conferences

Opus Genetics to Present OPGx-BEST1 Cohort 1 Clinical Data in Investor Webcast and at Upcoming Leading Ophthalmology Conferences

Opus Genetics announced it will present topline data from Cohort 1 of its Phase 1/2 study of OPGx-BEST1 gene therapy targeting BEST1-related inherited retinal diseases. The data presentation is scheduled for September 9, 2026, followed by full clinical datasets at major ophthalmology conferences. OPGx-BEST1 uses an AAV vector to deliver a functiona…

CoinShares Completes Acquisition of Bastion Asset Management

CoinShares Completes Acquisition of Bastion Asset Management

CoinShares PLC has completed the acquisition of Bastion Asset Management, integrating Bastion's systematic investment team and strategies into its Active Alternative Strategies business. The acquisition enhances CoinShares' ability to offer both passive and active digital asset investment strategies, broadening its institutional platform and produc…

Can-Fite Reports Longer-Than-Anticipated Overall Survival in Ongoing Pivotal Phase III Liver Cancer Study

Can-Fite Reports Longer-Than-Anticipated Overall Survival in Ongoing Pivotal Phase III Liver Cancer Study

Can-Fite BioPharma reports that overall survival in its ongoing pivotal Phase III trial of Namodenoson for advanced hepatocellular carcinoma (HCC) is longer than initially expected, prompting plans to advance the interim analysis. While the trial remains blinded, this positive signal may indicate potential clinical benefit for patients with substan…

WRAP Moves to Operationalize De-Escalation, Advances New BolaWrap 150 Doctrine Toward California POST Certification

WRAP Moves to Operationalize De-Escalation, Advances New BolaWrap 150 Doctrine Toward California POST Certification

Wrap Technologies announced the development of a new law enforcement doctrine and training curriculum designed to operationalize de-escalation utilizing its BolaWrap 150 device, recently classified by the ATF as an instrument of restraint rather than a firearm. The company has submitted the curriculum for independent validation and California Peace…

Rapport Therapeutics to Participate in Upcoming Investor Conferences

Rapport Therapeutics to Participate in Upcoming Investor Conferences

Rapport Therapeutics, a clinical-stage biotech company focused on precision small molecule medicines for neurological and psychiatric disorders, will participate in upcoming investor events including the Cantor Global Healthcare Conference and TD Cowen Neuropsychiatry Summit. Management will discuss its RAP technology platform and lead drug candida…

Paramount Gold Announces BLM Approval of Plan of Operations and Determination of Financial Guarantee for the Grassy Mountain Project

Paramount Gold Announces BLM Approval of Plan of Operations and Determination of Financial Guarantee for the Grassy Mountain Project

Paramount Gold Nevada Corp. announced that the U.S. Bureau of Land Management approved its Plan of Operations for the Grassy Mountain Gold Project in Oregon and agreed the financial guarantee for reclamation is sufficient. With this federal permitting milestone achieved, Paramount expects to finalize state permits later this year and is preparing t…

CDT Provides Capital Update and Confirms No Nasdaq Deficiencies

CDT Provides Capital Update and Confirms No Nasdaq Deficiencies

CDT Equity Inc. reported that it has 13,693,866 shares outstanding as of August 31, 2026, with a market capitalization of approximately $23 million. The company confirmed it has resolved all deficiencies with Nasdaq, improving its standing on the exchange. CDT Equity Inc. is a biopharmaceutical company advancing therapeutic assets through AI and sc…

Skyworks Announces Extension of Expiration Date of Exchange Offers for Qorvo’s Senior Notes due 2029 and 2031

Skyworks Announces Extension of Expiration Date of Exchange Offers for Qorvo’s Senior Notes due 2029 and 2031

Skyworks Solutions has extended the expiration date of its exchange offers allowing Qorvo senior noteholders to swap their notes for new Skyworks notes. This move is part of the ongoing merger process between Skyworks and Qorvo, with the companies targeting closure within the calendar year. Approximately 90% or more of Qorvo's outstanding senior no…

Quantumsphere Acquisition Corporation Announces Termination of the Agreement and Plan of Merger with SACH Pte. Ltd.

Quantumsphere Acquisition Corporation Announces Termination of the Agreement and Plan of Merger with SACH Pte. Ltd.

Quantumsphere Acquisition Corporation announced the termination of its previously agreed merger with SACH Pte. Ltd. The company delivered the termination notice following an unaddressed thirty-day period after highlighting certain matters under the merger agreement. Quantumsphere plans to continue exploring other potential business combinations.

Quantum BioPharma Announces Plans to Voluntarily Delist its Class B Shares from the Canadian Securities Exchange

Quantum BioPharma Announces Plans to Voluntarily Delist its Class B Shares from the Canadian Securities Exchange

Quantum BioPharma Ltd. announced it has applied to voluntarily delist its Class B subordinate voting shares from the Canadian Securities Exchange (CSE) due to low trading volume and associated costs. The shares will continue trading on Nasdaq, Frankfurt Stock Exchange, and Upstream, consolidating liquidity on a principal marketplace. The company re…